PATRICIA J. ZETTLER is an associate professor at The Ohio State University Moritz College of Law and a faculty member of Ohio State’s Drug Enforcement and Policy Center and its Comprehensive Cancer Center. Her research and teaching focus on FDA law and policy, torts, and legislation and regulation. Her scholarship has appeared in leading legal and health sciences journals such as the Food and Drug Law Journal, Indiana Law Journal, the Boston College Law Review, New England Journal of Medicine, JAMA, and Science, and has covered various topics including expanded access, stem cell interventions, opioids, cannabis products, tobacco and nicotine products, and COVID-19 countermeasures. Zettler also is a co-author of the forthcoming 5th edition of Food and Drug Law: Cases and Materials (with Peter Barton Hutt, the late Richard A. Merrill, Lewis A. Grossman, Nathan Cortez, and Erika Lietzan). She currently serves on the Food and Drug Law Institute’s (FDLI) Board of Directors and on the International Society of Cell & Gene Therapy’s (ISCT) Committee on the Ethics of Cell and Gene Therapy. She also chairs ISCT’s working group on expanded access. Previously she served on the National Academies of Sciences, Engineering, and Medicine’s (NASEM) Committee on Reviewing the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), on FDLI’s Black Lives Matter Advisory Committee, on the International Society for Stem Cell Research’s Task Force to Revise Guidelines, on the Food and Drug Law Journal’s Editorial Advisory Board, and as a consultant to the NASEM Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Before entering academics, Zettler served as an attorney in the Office of the Chief Counsel at FDA. She received her undergraduate and law degrees from Stanford University, both with distinction.